Cryoglobulinemic Vasculitis
📧 Sign up to get email alerts when something new happens for Cryoglobulinemic Vasculitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the effectiveness and immune response of IL-2 therapy in patients with hepatitis C virus–associated cryoglobuline…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab [Phase 2]
A multicenter Phase 2, single-arm proof-of-concept trial is evaluating obinutuzumab for non-infectious active cryoglobulinemic vasculitis in…
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis [Phase 2]
This update reports results from a Phase 2 trial of a biologic therapy for refractory primary non-ANCA associated vasculitis; the study was …
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Isatuximab in Type I Cryoglobulinemia [Phase 2]
Phase 2 trial update for isatuximab in cryoglobulinemic vasculitis associated with monoclonal gammopathies isatuximab is being studied; curr…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis [Phase 2]
This update summarizes a Phase 2 trial evaluating rituximab for hepatitis C–associated cryoglobulinemic vasculitis. The study has completed …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.